A novel therapeutically active anti-TNFR2 agonistic antibody promotes Treg proliferation and induction of Treg functional markers By webadmin@biolojic.com|2024-08-06T09:42:32+00:00July 10, 2024|Publication|0 Comments Read More
A Novel Computationally Designed Multibody Targeting IL-13/TSLP for Precision Therapy in TH2-Mediated Diseases By webadmin@biolojic.com|2024-08-06T09:35:51+00:00May 14, 2024|Publication|0 Comments Read More
Redirecting an anti-IL-1β antibody to bind a new, unrelated and computationally predicted epitope on hIL-17A By webadmin@biolojic.com|2024-08-13T11:38:01+00:00September 9, 2023|Publication|0 Comments Read More
Accurate profiling of full-length Fv in highly homologous antibody libraries using UMI tagged short reads By webadmin@biolojic.com|2024-08-26T08:57:55+00:00June 23, 2023|Publication|0 Comments Read More
Computational Engineering of a Therapeutic Antibody to Inhibit Multiple Mutants of HER2 Without Compromising Inhibition of the Canonical HER2 By webadmin@biolojic.com|2024-08-26T08:53:18+00:00March 29, 2023|Publication|0 Comments Read More
The computationally designed human antibody, AU-007, mediates human immune activation by endogenous IL-2, while uniquely breaking the IL-2 auto-inhibitory loop and preventing Treg expansion By webadmin@biolojic.com|2024-08-13T11:34:42+00:00November 10, 2021|Publication|0 Comments Read More
Biolojic’s anti IL2 antibody covered in Nature’s review of current IL2 therapies in development By Brandon Tilley|2023-06-20T20:59:31+00:00February 21, 2021|Publication|0 Comments Read More
Computational Design of Epitope-Specific Functional Antibodies By webadmin@biolojic.com|2024-08-13T11:33:37+00:00November 20, 2018|Publication|0 Comments Read More
